HomeCategory Wearables

One of the few positive things coming out of the COVID-19 pandemic is dramatically heightened interest in telemedicine. Telemedicine visits have jumped from 0.1% of Medicare primary care visits in February 2020 to 43.5% in April1, according to the US Department of Health and Human Services. Virtual visits are more convenient for patients, reduce the risk of contagion, and are more efficient for healthcare systems. Given the dramatic increase in telemedicine visits, one would expect...

By Martina Donohue & Geoffrey Gill Few will disagree that pharmaceutical development costs too much and takes too long. Drug development often lasts longer than a decade and costs anywhere between $2 and $3 billion, according to a Tufts Center for the Study of Drug Development R&D Cost Study [1]. It is also widely accepted that wearable sensors create the potential for new endpoints that can reduce cost, shorten clinical trials, and focus trials on...